Kiprop: Doping Accusation Worse than Terrorism

Triple 1500m World Champion, Asbel Kiprop, continues his fight against what he terms as ‘false’ doping allegations.

The Olympic star has refused to go down without a fight since the Athletics Integrity Unit (AIU) confirmed he had tested positive for banned substance recombinant erythropoietin (EPO) and was subsequently charged on March 16, 2018.

Kiprop, the third fastest 1500m runner in history, has used every chance to insist on his innocence.

He seemed to have given it all up when in mid June, he posted on his Facebook account saying: “I have let the struggle to prove my innocence go. Not because I doped but I take the sacrifice because I support the anti-doping campaign.”

Keeping the fight

However, a post on his Twitter account on July 29 suggests that ‘aluta continua’. The former Olympic champion Tweeted: “What I’m facing today! Not even the strongest man on Earth can withstand. FALSE DOPING ACCUSATION is worst than Terrorism. Especially when it affects a clean athlete who have lived & genuinely realised the dream.”

Tagged on the post were International Association of Athletics Federations (IAAF) President Sebastian Coe, the IAAF itself and AIU.

He later added: “Living in isolation for an allegations that you didn’t commit makes you acknowledge that some people’s negligence can hurt others human rights.”

The 29-year-old was awarded the 2008 Beijing Olympics 1500m gold after the original winner, Rashid Ramzi, tested positive for doping.

Doping menace

Kiprop is one among a list of Kenyan athletes who have either been accused of or found guilty of doping.

Three time Boston Marathon champion Rita Jeptoo tested positive for EPO in 2014 while 2016 Olympic marathon champion Jemima Sumgong is serving a four-year ban after her defence of taking EPO for an ectopic pregnancy was thrown out.

Others Kenyan athletes serving bans include Joyce Zakari and Francisca Koki and two-time World Cross Country champion Emily Chebet.

By Steve Ayoo (@Steifmaster 88)

Share

Leave a Reply